Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23323)

Formulation Name
Voxelotor 500 mg tablet
Company
Global Blood Therapeutics
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Voxelotor DMCS6M5 Sickle-cell disorder 3A51 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Carmellose sodium E00625 Not Available Disintegrant
Cellulose microcrystalline E00698 Not Available Adsorbent; Suspending agent; Diluent
Colcothar yellow E00436 518696 Colorant
Hydrophobic colloidal silica E00285 24261 Anticaking agent; Emulsion stabilizing agent; Glidant; Suspending agent; Viscosity-controlling agent
Magnesium stearate E00208 11177 lubricant
Polyethylene glycol 3350 E00652 Not Available Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Polyvinyl alcohol E00666 Not Available Coating agent; Emulsion stabilizing agent; Film/Membrane-forming agent
Sodium lauryl sulfate E00464 3423265 Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Talc E00520 16211421 Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent